整合基因表达谱与临床因素列线图的开发与验证:用于准确预测Mohs显微描记手术后皮肤黑色素瘤患者的转移
研究前瞻性纳入9个Mohs显微描记手术中心的1124例患者,用684例(随访至少1年或发生转移)数据开发整合31基因表达谱(31-GEP)与T分期的列线图,并在901例档案队列中验证;列线图预测转移风险较T分期或31-GEP单独更准确。
要点
- 31-GEP联合T分期的列线图预测皮肤黑色素瘤转移风险优于T分期或31-GEP单独。
- 列线图在901例档案队列中验证,观察风险与预测风险呈显著线性相关。
- 多数患者未行前哨淋巴结活检,故列线图未纳入该指标。
核心结论
- 整合31-GEP与T分期可从无创获得的数据中获取有临床意义的预后信息。
研究设计与样本
- IRB批准的前瞻性研究,纳入9个Mohs显微描记手术中心的1124例患者,均接受Mohs显微描记手术并完成31-GEP检测。
- 采用684例随访至少1年或发生转移事件的患者数据开发列线图以预测转移风险。
- 在901例档案队列中验证列线图。
主要发现
- 对31-GEP结果与T分期进行逻辑回归建模,得到贝叶斯信息准则评分最低的最简列线图。
- 在901例档案队列验证中,观察到的转移风险与列线图预测风险呈显著线性相关。
- 列线图预测皮肤黑色素瘤转移风险较T分期或31-GEP单独更准确。
局限性
- 患者人群仅代表Mohs显微描记手术中心。
- 多数患者未行前哨淋巴结活检,该指标无法用于列线图。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a need to improve prognostic accuracy for patients with cutaneous melanoma. A 31-gene expression profile (31-GEP) test uses the molecular biology of primary tumors to identify individual patient metastatic risk. OBJECTIVE: Develop a nomogram incorporating 31-GEP with relevant clinical factors to improve prognostic accuracy. METHODS: In an IRB-approved study, 1124 patients from 9 Mohs micrographic surgery centers were prospectively enrolled, treated with Mohs micrographic surgery, and underwent 31-GEP testing. Data from 684 of those patients with at least 1-year follow-up or a metastatic event were included in nomogram development to predict metastatic risk. RESULTS: Logistic regression modeling of 31-GEP results and T stage provided the simplest nomogram with the lowest Bayesian information criteria score. Validation in an archival cohort (n = 901) demonstrated a significant linear correlation between observed and nomogram-predicted risk of metastasis. The resulting nomogram more accurately predicts the risk for cutaneous melanoma metastasis than T stage or 31-GEP alone. LIMITATIONS: The patient population is representative of Mohs micrographic surgery centers. Sentinel lymph node biopsy was not performed for most patients and could not be used in the nomogram. CONCLUSIONS: Integration of 31-GEP and T stage can gain clinically useful prognostic information from data obtained noninvasively.
引用
- Thorpe RB, Covington KR, Caruso HG, et al. Development and validation of a nomogram incorporating gene expression profiling and clinical factors for accurate prediction of metastasis in patients with cutaneous melanoma following Mohs micrographic surgery. J Am Acad Dermatol. 2021. PMID: 34808324. doi:10.1016/j.jaad.2021.10.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。